Treatment of Relapsed/Refractory Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Published:2017-03 Issue:3 Volume:18 Page:
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Bose Prithviraj,Vachhani Pankit,Cortes Jorge E.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11864-017-0456-2.pdf

Reference142 articles.

1. Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–52.

2. Rowe JM, Tallman MS. How I treat acute myeloid leukemia. Blood. 2010;116:3147–56.

3. Forman SJ, Rowe JM. The myth of the second remission of acute leukemia in the adult. Blood. 2013;121:1077–82.

4. Ravandi F, Estey EH, Appelbaum FR, Lo-Coco F, Schiffer CA, Larson RA, Burnett AK, Kantarjian HM. Gemtuzumab ozogamicin: time to resurrect? J Clin Oncol. 2012;30:3921–3.

5. •• Lancet JE, Uy GL, Cortes JE, Newell LF, Lin TL, Ritchie EK, Stuart RK, Strickland SA, Hogge D, Solomon SR, Stone RM, Bixby D, Kolitz JE, Schiller GJ, Wieduwilt MJ, Ryan D, Hoering A, Chiarella M, Louie AC, Medeiros BC. Final results of a phase III randomized trial of CPX-351 versus 7 + 3 in older patients with newly diagnosed high risk (secondary) AML. J Clin Oncol. 2016;34:7000. Results of the pivotal trial of CPX-351 in older patients with newly diagnosed secondary AML showing a survival benefit for this agent.

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2025-01

2. Inhibition of Acute Myeloid Leukaemia Development by Bittersweet Based on miR-let-7a Regulating Vascular Endothelial Growth Factor A Resistance Mechanism;Journal of Biobased Materials and Bioenergy;2024-12-01

3. Clinical Significance and Potential Function of Complement Factor D in Acute Myeloid Leukemia;Cureus;2024-08-20

4. Safety, Efficacy, and Predictive Factors of Venetoclax-Based Regimens in Elderly Acute Myeloid Leukemia Patients: A Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2024-08

5. C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial;Nature Communications;2024-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3